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Abstract
Background: Long-term conditions and their concomitant management place considerable pressure on patients, communities,
and health care systems worldwide. International clinical guidelines on the majority of long-term conditions recommend the
inclusion of self-management programs in routine management. Self-management programs have been associated with improved
health outcomes; however, the successful and sustainable transfer of research programs into clinical practice has been inconsistent.
Recent developments in mobile technology, such as mobile phone and tablet computer apps, could help in developing a platform
for the delivery of self-management interventions that are adaptable, of low cost, and easily accessible.
Objective: We conducted a systematic review to assess the effectiveness of mobile phone and tablet apps in self-management
of key symptoms of long-term conditions.
Methods: We searched PubMed, Embase, EBSCO databases, the Cochrane Library, and The Joanna Briggs Institute Library
for randomized controlled trials that assessed the effectiveness of mobile phone and tablet apps in self-management of diabetes
mellitus, cardiovascular disease, and chronic lung diseases from 2005–2016. We searched registers of current and ongoing trials,
as well as the gray literature. We then checked the reference lists of all primary studies and review papers for additional references.
The last search was run in February 2016.
Results: Of the 9 papers we reviewed, 6 of the interventions demonstrated a statistically significant improvement in the primary
measure of clinical outcome. Where the intervention comprised an app only, 3 studies demonstrated a statistically significant
improvement. Interventions to address diabetes mellitus (5/9) were the most common, followed by chronic lung disease (3/9)
and cardiovascular disease (1/9). A total of 3 studies included multiple intervention groups using permutations of an intervention
involving an app. The duration of the intervention ranged from 6 weeks to 1 year, and final follow-up data ranged from 3 months
to 1 year. Sample size ranged from 48 to 288 participants.
Conclusions: The evidence indicates the potential of apps in improving symptom management through self-management
interventions. The use of apps in mHealth has the potential to improve health outcomes among those living with chronic diseases
through enhanced symptom control. Further innovation, optimization, and rigorous research around the potential of apps in
mHealth technology will move the field toward the reality of improved health care delivery and outcomes.
(J Med Internet Res 2016;18(5):e97)   doi:10.2196/jmir.4883
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Introduction
The number of people living with 1 or more chronic disease
continues to increase worldwide [1]. Improvement in living
conditions and treatment has increased the life expectancy of
people with chronic conditions; however, without effective
management, quality of life may be poor. Empowering and
engaging people with chronic diseases to manage their own
health is vital. Several barriers have been identified in the ability
of the individual and health care providers to work together to
promote self-management [2]. Having access to timely
information, assessment, and treatment are all vital in the
management of long-term conditions [3]. mHealth interventions
offer the potential to overcome many of the traditional barriers
by offering convenience and care in a natural environment and
minimizing the barriers of distance, time, and cost. For the
clinician, mHealth interventions offer the ability to evaluate a
prescribed course of action, monitor adverse events, and identify
areas for improvement [4,5].
For the past decade, mHealth has been constantly expanding as
a subdivision of eHealth. Mobile apps for health have the
potential to target heterogeneous populations, but with the ability
to also address specific needs and complement highly developed
health care technologies. The market is evolving rapidly,
generating myriad opportunities for the development of new
mobile technologies [6].
Mobile phones (ie, mobile phones with advanced computing
and Internet access) and tablet computers (ie, general purpose
computers contained in a single panel and usually operated
through a touch screen) have become the most popular and
widespread types of mobile device [7]. Close to 55% of British
adults claim to own a mobile phone [8] and over a third own a
tablet [9]. In the United States, a report by the Pew Research
Center found that 64% of all adults now own a mobile phone
[10] and 34% of American adults own a tablet computer [11].
Worldwide, just under 17% of the 6 billion mobile subscriptions
are mobile phone subscriptions [12]. As retail prices decline,
ownership of these devices is likely to continue to increase [8]
in high-income and low- and middle-income countries.
Mobile apps are increasingly used in managing various tasks
in daily life. More than 900,000 apps are available in the Apple
App Store (iOS operating system; Apple Inc) and more than
700,000 apps in the Google Play Store (Android operating
system; Google). Over 100,000 of these are health-related apps.
Sophisticated computing features mean that both mobile phones
and tablet computers can support self-management functions
and deliver them at a population level. Self-management
interventions could be offered within software extensions that
users add to their devices, popularized under the term apps [13].
Methods
Overview
We undertook a systematic review of apps used to facilitate
self-management of long-term conditions with an outcome focus
on the key disease markers and symptoms. The long-term
conditions were diabetes mellitus, cardiovascular diseases, and
chronic lung diseases. Cardiovascular diseases include
hypertension, coronary artery disease, and congestive heart
failure. Chronic lung diseases include asthma and chronic
obstructive pulmonary disease. We chose these conditions on
account of their high global burden [14].
Our definition of self-management apps was software programs
designed for mobile phones and tablets that aim to promote or
support self-management skills to manage the key disease
markers and symptoms. Apps are optional add-ons to the device
that interact with users through a set of interfaces (eg, a visual
user interface). Health apps can be characterized as a medium
with broad capabilities to communicate information, provide
interactive experiences, and collect information from patients.
They provide a platform for the delivery of self- management
interventions that are highly adaptable, of low cost to the health
system, and easily accessible.
Using Boolean phrases, we searched PubMed, Embase and
EBSCO databases for studies that assessed the effectiveness of
apps in the management of diabetes, cardiovascular diseases,
and chronic lung diseases. We searched PubMed using Medical
Subject Headings and advanced search builder features. Emtree
terms using the explosion function to extend the search were
used to build a multiterm query along with advanced searches
in Embase. We included CINAHL, PsycINFO, and
PsycARTICLES in the EBSCO database search. We
handsearched the JMIR journals and Telemedicine Journal and
e-Health as the key publications for this area of research. We
examined the reference lists of all papers included in the review
and removed duplicates. The databases were searched between
2005 and 2016, since technologies prior to 2005 are unlikely to
be representative of contemporary technologies that support
health apps [15-17]. In addition, the concept of self-management
was not widely adopted prior to 2005. We completed the final
search in February 2016 (Textbox 1). The Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
statement guided the reporting of the review [18].
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Textbox 1. PubMed search strategy (terms).
1. Pulmonary disease, chronic obstructive
2. asthma
3. Acute coronary syndrome
4. Blood glucose
5. Blood pressure
6. Coronary Disease
7. Cardiovascular diseases
8. Diabetes mellitus
9. Forced expiratory volume (FEV)
10. Hemoglobin A, glycosylated
11. Hypertension
12. Computers, Handheld
13. Peak expiratory flow rate
14. Cell Phones
15. MP3-Player
16. Telemedicine
17. Or/1-16
18. Limit 17 to yr=2005-Current
Inclusion and Exclusion Criteria
We included original research published in peer reviewed
journals that evaluated self-management apps for their effect
on disease-specific clinical outcomes. The focus on
disease-specific clinical measures such as glycated hemoglobin
(HbA1c) or blood pressure was chosen because improved clinical
outcomes are the ultimate goal (in terms of quality-adjusted life
years, disease burden, and health care costs) of self-management
programs. Included studies were randomized controlled trials
(RCTs) of self-management interventions for patients with a
clinician-diagnosed long-term condition delivered via mobile
phone apps compared with either self-management interventions
delivered via traditional methods (eg, paper-based diaries) or
usual care.
We excluded papers if (1) they reported on primary prevention
among healthy or at-risk groups, (2) the focus lay outside of the
self-management domain (see Textbox 2 for
self-management-related activities [3,19]), (3) the sample did
not include people living with diabetes, cardiovascular diseases,
or chronic lung diseases or where the results from the subsample
of the populations of interest were not distinctly reported, or
(4) the intervention targeted health care professionals; required
modification of hardware; relied solely on messaging (short
message service or multimedia message service); did not offer
a mode of interaction (this could be automated and based on
logarithms), acting only as a transmitter of data (eg, from patient
to clinician), because this would be more reflective of
telemonitoring; or used devices that did not offer portability
comparable with mobile phones and tablets (eg, desktops,
laptops, notebooks, and netbooks)—although these are portable,
they are not accessible at all times regardless of location. In
addition, we excluded review papers, editorials, commentaries,
dissertations, poster presentations, abstracts only, proposals for
future studies, study protocols, and descriptive papers describing
apps but not testing them in a sample population. Publication
language was restricted to English only.
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Textbox 2. Patients’ self-management characteristics (adapted from Lahdensuo [ 19] and Battersby et al [ 3]).
• Accept the condition as a long-term disease amenable to intervention
• Have knowledge about the disease and its treatment
• Actively participate in the control and management of the disease
• Identify factors that make the condition worse
• Be able to describe strategies for avoidance or reduction of exacerbating factors
• Recognize the signs and symptoms of deterioration in health
• Follow a prescribed, written treatment plan
• Use correct technique for taking drugs
• Take appropriate action to prevent and treat symptoms in different situations
• Use medical resources appropriately for routine and acute care
• Monitor symptoms and objective measures of disease control
• Identify barriers to adherence to the treatment plan
• Address specific problems that have an impact on the individual’s condition
Data Extraction and Analysis
We initially screened publications for potential inclusion based
on simultaneous review of title and abstract by 2 reviewers.
Any discrepancies were resolved by consensus between the
reviewers with reference to the full paper. Information extracted
from each paper using a structured form included objectives,
types of intervention, setting, sample characteristics, outcomes
measured, and results reported. We assessed risk of bias for all
included studies using the Cochrane Collaboration’s tool for
assessing the risk of bias in RCTs [20]. The 2 reviewer authors
independently assigned each domain of the Cochrane
Collaboration’s tool of each individual study to 1 of 3 categories:
low, high, or unclear risk of bias. For each study, we created a
risk-of-bias table.
We performed descriptive analyses of the data and summarized
the findings from these studies, with emphasis on statistical
results reported in RCTs. Differences between groups were
highlighted when these results were available. Outcomes were
organized into disease-specific clinical outcomes of the
intervention. Where available, the usability, feasibility, and
acceptability of the intervention were described.
Results
Summary
In all, we reviewed the title or abstract, or both, of 893 papers
as retrieved by the database searches. We retrieved 14 papers
in full text and assessed them for eligibility. We excluded 5
papers because they did not meet the study design criteria. A
total of 9 papers met all inclusion criteria. Figure 1 illustrates
the selection process. Multimedia Appendix 1 sets out the quality
of the included studies, based on the risk-of-bias assessment.
The area in which all studies were assigned a rating of high risk
was “blinding of participants and personnel (performance bias).”
Due to the nature of the intervention, participants could not be
blinded in any of the studies. In some of the studies the
personnel involved were also aware of to which group
participants were assigned.
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Figure 1. Selection process.
Study Characteristics
Publication years ranged from 2008 to 2014 (Multimedia
Appendix 2). Studies were included from 4 geographic regions
(Europe, n=3; Oceania, n=2; Asia, n=3; United States, n=1).
All included studies were RCTs that assessed the effectiveness
of interventions that involved mobile phone- or tablet-assisted
self-management programs and either standard care (n=8) or
offline self-management programs (n=1) [21]. Of the
self-management group, 3 included multiple intervention groups
using permutations of an intervention involving an app.
Charpentier et al [22] ran 2 intervention groups: 1 group used
an app plus quarterly clinical visits, and the second used an app
plus visits every 2 weeks. Quinn et al [23] ran 3 intervention
groups, all involving the patient using an app but with varying
degrees of information generated by the app sent to clinicians.
Holmen et al [24] ran 2 interventions, 1 using the app alone plus
usual care, and 1 using the app and monthly telephone
counselling. All 3 involved the use of an app and a Web portal
with differing levels of clinician support.
Interventions to address diabetes mellitus (5/9) were the most
common, followed by chronic lung disease (3/9) and
cardiovascular disease (1/9) interventions. The duration of the
intervention ranged from 6 weeks to 1 year, and final follow-up
data ranged from 3 months to 1 year. Sample size ranged from
48 to 288 participants.
Impact on Clinical Outcomes
All 9 studies reported the effect of the intervention apps on
disease-specific clinical outcomes (Table 1). Significant
differences between groups on the primary outcomes were
reported in 6 studies [21-23,25-27]. No significant differences
on the primary outcomes were found in 2 studies [24,28,29].
Of the 5 interventions related to improving diabetes management
[22-25,27], 2 related to type 1 diabetes [22,25] and 3 related to
type 2 diabetes [23,24,27]. Significant improvements in
diabetes-specific clinical outcomes (HbA1c) were reported in 4
studies [22,23,25,27], 2 relating to type 1 diabetes [22,25] and
2 relating to type 2 diabetes [23,27]. Only 1 study evaluated
apps for cardiovascular diseases [29]. Significant improvement
in the key clinical outcome, the 6-minute walking test, was
observed within the intervention group, indicating overall
improved physical functioning, but not between the 2
intervention groups. Mixed results were observed in chronic
lung disease clinical outcomes. Lung function parameters were
the primary outcomes of interest. Significant improvements
were reported in a study on asthma [26] and a study on chronic
obstructive pulmonary disease [21], but 1 study, on asthma [28],
did not report a significant change.
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Table 1. Effectiveness of interventions using mobile phone and tablet apps on primary clinical outcomes (n=9).
Total nNo significant effect, nSignificant effect, nLong-term condition addressed
202Diabetes mellitus type 1
312Diabetes mellitus type 2
110Cardiovascular disease
312Chronic lung diseases
936Total clinical outcome studies
Participants
The average age of participants in the studies ranged from 33.8
years [22] to 72.1 years [21]. The age of the participants in
relation to ability to use the technology and engagement was
not a focus in any study, and none of the studies excluded older
people specifically. Holmen et al [24] reported that users >63
years were significantly more likely than younger patients to
be substantial users of the app (P=.045).
The majority of studies focused on those with more severe
symptoms and clinical indicators outside of the normal range.
Of the studies on diabetes, 4 focused on those with HbA1clevels
above the optimal range [22-25], and 2 studies [21,26] focused
on people with moderate to severe chronic obstructive
pulmonary disease and asthma. The characteristics of the target
user group was often the impetus for the development of the
app tool or mHealth approach, citing the potential for reduced
travel to a medical center and ease of engagement as incentives
for self-management for these groups with greater symptom
burden or higher risk of burden in the future.
In 1 of the studies [25], participants had to provide the phone
(and presumably also the network connection) and in 1 study
[28], the participants were required to have a contract with a
compatible network at their own cost, though a phone could be
provided. Neither study noted any significant barriers in
recruitment as a result of this inclusion criterion. In all other
studies the equipment and the network setup and costs were
covered by the research study.
Interventions
The interventions differed in two main ways: the combination
of tools used in the intervention and the level of clinician input
(Multimedia Appendix 1). Thus, 2 studies [26,28] used an app
only and 3 studies ran 2 or 3 intervention groups, 1 of which
involved the use of an app only [22-24]. A total of 3 studies
[22,23,26] demonstrated a significant change in symptom
management and 2 [24,28] did not. An app plus feedback or
contact with participants, either by text (4 studies) or phone
conversation (3 studies), was used in 7 interventions. A total of
7 studies also used automatic text messages generated by the
app data, but only 2 studies [26,28] used this form of feedback
alone. In interventions that involved additional clinician input,
only 1 study standardized the enhanced clinical input across the
control group and intervention [26]. In 6 studies the level of
clinician input and support for the intervention group was
enhanced. In these studies, the effect of using an app cannot be
isolated, and the results cannot be interpreted in relation to
increased clinician input or support and the use of an app.
Of the 5 studies that explored the impact of using an app only
as the intervention tool on clinical outcomes [22-24,26,28], 3
studies [22,23,26] demonstrated a significant change in symptom
management and 2 [24,28] did not. Only 1 study isolated the
contribution of the app intervention where clinical care was
standardized for the intervention and control group [28]. The
study did not report a significant change in asthma symptom
control, with symptom control improving marginally in both
groups. Similar to the latter study, 4 studies standardized clinical
care, with both the control and intervention groups invited to
attend one outpatient appointment every 3 months [22-24,26],
as per best practice. However, a difference between these 4
studies and the study by Ryan et al [28] was the sharing of app
data ahead of the clinic visit [23,26] or the option of sharing the
app data during the scheduled clinic visits, in anticipation that
the data collected over time would inform the consultation and
medical management [22,24]. The impact of this is difficult to
quantify. In 2 studies [22,24], sharing data was by the patient’s
choice, and the number of patients who chose to do so was not
reported. In a study involving 2 intervention groups, the
effectiveness of the app-only intervention was significant,
although the effect size for the app-only intervention group was
not as big as that of the intervention group involving an app and
teleconsultations [22].
Another study [24] demonstrated an improvement in HbA1cin
all 3 groups (a control and 2 intervention groups), although the
improvement was not significant for any group. Interestingly,
HbA1cdecreased more in the app-only group (0.31) than in the
control group (0.16) and in the intervention group (0.15) that
also involved counselling. In a study on asthma [26], the data
were sent to the clinician ahead of the patient consultation, but
no data were reported on whether the clinician used this. Only
1 study [23] specifically sought to explore whether sending
clinicians’ data improved clinical outcomes. All 4 groups
continued with usual care (a review with their primary health
care provider every 3 months); however, intervention group 1
participants could choose to share their app-generated data with
their provider. For intervention group 2 participants, the clinician
was sent unanalyzed app-generated data before the scheduled
appointment. For intervention group 3 participants, the clinicians
were sent analyzed app-generated data ahead of the scheduled
appointment. What is not known is how many patients in
intervention group 1 shared their data with their clinicians, nor
how many clinicians viewed and used the data for participants
in groups 2 and 3 in their consultations. The outcome data are
mixed, with a decrease in HbA1cnoted for all 4 groups, and
significant differences noted between the control group and
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intervention groups 1 (P=.027) and 3 (P=.001), but not for
intervention group 2 (P=.40).
Safety Mechanisms
Only 3 studies [22,27,28] reported an inbuilt safety mechanism
for the app intervention, whereby a reading outside of the normal
range and considered aberrant enough according to the inbuilt
logarithm would trigger an alert. In 1 study [28], the alert would
be followed up by the asthma nurse linked with the study. In
another [27], an email was generated and sent to the principal
investigator and the research nurse. A further study noted the
parameters that would be considered abnormal but did not state
when or how readings outside of the normal range would be
followed up or to whom they would be sent [22]. No study
described whether cover included an out-of-hours service; 1
study reported that the data did not trigger any alerts [27]; and
the other 2 did not comment on the need for follow-up due to
abnormal readings [22,28].
Importantly, no study reported an increase in the number of
adverse events or need for additional hospital visits or medical
care as a result of participating in the interventions.
Training in the Use of Technology
A total of 5 studies [24,26-29] described training participants
in the use of the equipment and input of data. This ranged from
distance support [28] with a follow-up 1 week later, to
face-to-face support [24,29], and face-to-face support and a
2-week trial as to whether potential participants could use the
technology before they were included in the study [27]. Training
was mentioned by another study [26] but the nature of this was
unclear. In 4 studies participants were offered ongoing
technological support, if required, by telephone [24,27-29].
Technological Issues
Few technological issues were reported. Of the studies, 7
required participants to enter the data generated by the study
equipment into the app (or via the website) and 2 used a wireless
or Bluetooth-compatible device to transmit the data
automatically without requiring the participant to manually
submit the data [22,24]. No study reported on erroneous
imputations (by participants) and only 1 study [24] reported
errors in the transfer of data due to issues with the Bluetooth
pairing required for automatic transmission of data from the
glucometer to the app in the mobile phone.
No study reported on the number of calls participants or
clinicians made for technological support during the study.
However, 1 study did note that some participants who travelled
overseas incurred high mobile costs that weren’t covered by the
research study. The authors noted that this was anticipated, and
participants were informed about the different network rates if
travelling.
Usability, Feasibility, and Acceptability
Only 1 study sought to explore the usability and feasibility of
the app from the participants’ perspective [27], and 1 study
explored acceptability of the app from the health care provider’s
perspective [22]. All studies reported on attrition, which provides
some indication of the usability, feasibility, and acceptability
of the intervention. The attrition rates ranged from 8.75% [22]
to 26% [25]. Most studies reported the attrition rate for the
control and intervention groups combined. Where the attrition
rates were reported for the control and intervention groups
separately, of note, in 1 study, the attrition for the intervention
group was higher, with the study average at 25.83%, but the
intervention group alone was at 28.33% [26]. In another study,
the dropout rate in the usual-care group was considerably higher
(36.49% vs 13.21%) [29]. The usual-care group were enrolled
in a cardiac rehabilitation program. In a third study [23] the
attrition rate was as high as 31.82% in 1 of the intervention
groups (control group, 21.45%). The average attrition rate across
all 4 groups was 25.6%. No study noted any differences by
demographics or clinical parameters between those who dropped
out and completers.
A total of 3 studies reported on the number of participants who
dropped out specifically because of the technology or because
the frequency of input was too burdensome (6/17 [26], 3/7 [29],
and 2/3 people [27]).
Only 1 study reported that potential participants were excluded
because they could not use the technology [27]. In this study,
12 people were specially excluded before random allocation
because they were experiencing difficulties using the devices
and sending data. This equated to 18% of the group initially
recruited into the trial.
A total of 5 studies explored engagement with the intervention
over time and described these findings as a proxy for the
usability, feasibility, and acceptability of the intervention
[22,24-26,29]. In general, the studies found that the app or
intervention was usable, feasible, and acceptable to users. The
frequency of data entry was noted to decrease over time in 2
studies [24,25], and there was no significant relationship
between level of engagement and change in HbA1c. Another 2
studies reported adherence at the end point of the study as
evidence of acceptability (76.7% of the control group and 71.7%
of the intervention group [26]; 46.67% of the control group and
80% of the intervention group [29]). A further study asked
participants whether they wanted to continue with the
intervention if this were possible at the end of the study,
reporting that 67% of participants in the app-only intervention
and 75% in the app and teleconsultation intervention confirmed
that they would [22]. This study was the only one to report on
the health care provider’s perspective, reporting that 77% of
health care providers were satisfied or very satisfied (total
number of health care providers unknown). This study found
that the time spent by clinicians engaging with participants
across the groups was the same (average 71 minutes) but the
time saved by the intervention group that did not include hospital
clinic visits was 281 minutes (average travel time to attend 2
clinic visits). The time taken to upload data (wirelessly) was
estimated to be 10 seconds per day.
How participants felt about the time the intervention took and
how easily they had incorporated data entry into their daily life
was explored in 1 study [27]. Of 24 participants in the
intervention group, 14 felt that the daily data entry was easily
incorporated and 10 did not. The average time spent entering
data was 22.5 minutes per day. Compliance rates over time
(from baseline to the last 2 weeks of the study) for the
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components of the intervention differed, with a 70% compliance
rate (daily entry) for morning measurements, 50% compliance
for bedtime measurements, and 51.2% compliance related to
uploading a photo of a meal.
No study reported on the features of the app that patients or
health care providers found useful (eg, automated reminders,
text messages with educational and motivational content,
increased awareness), but 1 study did report that patients
expressed feeling reassured, knowing that their health symptoms
were regularly monitored [27]. Although the patients’
perspective wasn’t reported, 2 studies did find that the time
saved by not having to visit the hospital for follow-up as per
usual care was considerable [22,29].
Costs
The cost implications of using technology were considered in
2 studies. In 1 study where the participant provided the phone
and the network connection and a free app was used [25], the
cost to the study of messaging participants was calculated at
A$290.93, which equated to A $8.08 per participant (n=36).
The intervention also included input from a diabetes educator.
The diabetes educator spent on average 3 hours per week
reviewing participants’ logs and text messaging participants,
equating to 5 minutes per participant, per week (72 hours in
total over the 6-month period). With the hourly rate of A$28.85,
the cost to the study was A$2077.20.
The second study required the participant to provide the phone
and cover network costs. The technological support service for
participants and nursing cover (the safety mechanism for
abnormal readings) were contracted out to the company that
developed the software, and this was the only cost incurred (not
disclosed).
Discussion
Principal Findings
The evidence presented indicates the potential of apps in
improving symptom management through self-management
interventions. Of the 9 studies, 6 reported a statistically
significant difference in the primary clinical outcome of interest.
Where the intervention comprised an app only, 3 studies
demonstrated a statistically significant improvement. The
interventions differed in two main ways: the combination of
tools used in the intervention and the level of clinician input
(Multimedia Appendix 1). A total of 2 studies [26,28] used an
app only and 3 studies ran 2 or 3 intervention groups, 1 of which
involved the use of an app only [22-24]. Symptom management
changed significantly in 3 studies [22,23,26] but not in 2 [24,28].
An app plus feedback or contact with participants, either by text
(4 studies) or phone conversation (3 studies), was used in 7
studies; 7 studies also used automatic text messages generated
by the app data, but only 2 studies [26,28] used this form of
feedback alone. In interventions that involved additional
clinician input, only 1 study standardized the enhanced clinical
input across the control group and intervention [26]. In 6 studies
the level of clinician input and support for the intervention group
was enhanced. In these studies, the effect of using an app cannot
be isolated, and the results cannot be interpreted in relation to
increased input or support and the use of an app.
Given the evidence that monitoring alone improves symptom
control [30], in our review we sought to understand the
contribution an intervention involving an app can make.
Separating the effect of monitoring alone was not possible in
this review. None of the interventions included a study group
that involved telemonitoring only. All of the interventions
involved either real-time automated feedback or
clinician-initiated feedback based on the data entered. The
second issue confounding the findings regarding the contribution
of the app to symptom management was the use of additional
interventions, in combination with the app, to support symptom
management.
A further note of caution relates to the ability to generalize the
findings to the clinical setting. All of the studies referred to
clinical care during the study period as relating to best practice
and may indicate an improvement in the actual usual care
received. Aside from 1 study [28] where a nurse was employed
to ensure follow-up appointments every 3 months, the clinical
follow-up appears to have been undertaken in real-life,
usual-care clinical settings, although the prompt for data
collection at the 3-month time points may have increased the
likelihood of these appointments being scheduled and kept. In
1 study [28] the authors specifically noted that, although the
clinical care provided during the study period was set up to be
in line with best practice with 3-month follow-up appointments,
this was likely an improvement in clinical support for the study
participants and that it remains unknown whether the addition
of the app could improve clinical outcomes when clinical care
is less than optimal.
A total of 7 interventions involved the use of the app and a
degree of clinical input or support. It does not appear that the
intensity of support necessarily affected the outcome, nor the
mode of support (eg, electronic, verbal, or face to face). All of
the interventions that involved weekly support did note a
significant improvement in symptom control, and interventions
with a greater gap in time between contact noted mixed results.
However, interventions without additional clinical input between
usual clinical visits also showed a significant improvement.
More frequent clinical input or engagement does not appear to
be vital in effecting change in symptom management.
All studies reported minimal issues related to usability. It
appears that apps can be used by those with little technology
experience or familiarity. The apps do, however, rely on the
active engagement of the user. In this review, we could not
discern how frequent the level of engagement between user and
app needs to be and for how long in order to effect long-term
change in symptom management. The engagement of health
care providers in monitoring symptoms and exchanging
information with users would be desirable in terms of promoting
partnership in care, although, again, how important this is in
effecting improvements in symptom management is not clear
from the review. The freedom and portability of mobile devices,
combined with the advanced capacity to facilitate 2-way
communication and collect and analyze data for a real-time
response, offer enormous potential to patients and health care
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providers. The potential complexity of today’s mHealth tools
and the mixed evidence on the features that are important and
make a difference in their effectiveness indicate a need for a
focus on understanding the connection between patient
experience, adherence, and health outcomes.
The involvement of end users in the development of apps and
also specific groups, such as older people and those from
different cultures, was not a strong feature in the interventions
reviewed. An iterative design process involving systems and
content development and multiple stages of user experience
testing is recommended for future apps aimed at similar patient
populations [31]. The wider evidence suggests that diverse
groups can use apps with sufficient training and provision of
support [4,32,33], although the level of support over time in
both areas remains relatively unexplored.
Technical problems did not feature highly in the review. The
issue of erroneous imputations was not mentioned, and errors
in transfer of data was noted in only 1 study. However, these
areas have been raised in other studies as requiring regular
monitoring and attention [34,35].
Given the multitude of apps available, advice on how to develop
a “good” app or assess the “quality” of an app when reviewing
the existing apps available has important ethical and legal issues
for both research and clinical practice. The market has low entry
barriers, and ease of accessibility for users through mobile
phones and tablets makes this an attractive area for both private
and professional areas of application. In health care, when
mobile smart devices are used in combination with add-ons that
are connected either directly or via wireless technology—for
example, blood glucose monitors—manufacturers are required
to conform to the laws and regulations that are in place for
medical devices, although, depending on the jurisdiction, apps
may or may not be well adapted to the specifics of mobile
devices. Regulation usually encompasses an app running on a
smart device and, for the health professional and patient, some
reassurance as to the level of trustworthiness. Stand-alone smart
devices and the apps running on them may pose a significant
threat to a patient’s safety and privacy if the necessary safety
measures are not observed. Before recommending or developing
an app, it is vital that the functionality be thoroughly tested with
respect to the potential for miscalculations, erroneous or
incomplete content, technical deficiencies, and other usage
restrictions. In addition, assessing the validity of the information
and advice regarding symptom management is vital, as well as
safety mechanisms relating to when to seek urgent medical
advice and support.
The issue of adherence over time was reported by some studies
in the review and was found to be unrelated to clinical outcome,
that is, those who continued to input data and those who were
classified as substantial users did not differ from those whose
input declined over time. However, the issue of maintaining
engagement over the course of a study and beyond into everyday
life is a major consideration and highly likely to affect long-term
symptom control. There is a growing understanding of barriers
to adherence and ways to overcome them. The development of
mAdherence tools to explore barriers to maintaining engagement
is growing and will be important in the development of mHealth
interventions. In this review we noted differences in
patient-provider communication and in the use of targeted
motivational messages, but we were not able to qualify their
impact.
The issue of enhancing adherence goes beyond maintaining
engagement of patients using apps. The development of mHealth
tools for chronic disease management could unintentionally
increase health disparities in access to technology. Vulnerable,
hard-to-reach, or otherwise high-risk patient populations run
the risk of exclusion. Where mHealth tools have the potential
to engage patients who are less inclined to use traditional health
services, mHealth tools offers a way to address barriers to care
and reduce health disparities. It is important that future studies
specifically build on these areas and reduce the risk of generating
a range of interventions largely unused by those who could
benefit the most.
Few of the studies we reviewed discussed the issue of cost. The
majority of the studies provided the devices to study participants.
When implemented at scale, interventions that use patients’
existing mobile devices rather than relying on gifted devices
will go further toward explaining feasibility and improving
clinical outcomes. Rigorous cost-effectiveness analyses will be
necessary to demonstrate not only the health impact, but also
the value of investing in these innovations.
In addition to cost barriers, other potential barriers for
consideration are language and literacy barriers, as well as
availability and connectivity issues. Perhaps most critically, if
adherence to chronic disease management is not encouraged
and actively practiced, it is unlikely that mHealth tools, which
are communication platforms and delivery mechanisms, not
solutions in and of themselves, will be effective. Conditions
such as capability, opportunity, and motivation are essential to
behavior change [36]. For example, in diabetes, to improve
HbA1c, management of healthy eating, physical activity, and
adherence to medication are all important, yet we know little
about how we can support and effectively motivate a person in
all 3 areas through an app. This again points to the need in future
research for the involvement of users as part of the team when
developing interventions.
Limitations
There are limitations to this systematic review. A meta-analysis
was not possible due to the heterogeneity of the study designs.
We did not include non-English literature. The diversity of study
objectives, designs, and outcomes made clear comparisons
difficult, and the quality of evidence was variable.
Our review expands the evidence base by extending the
definition of app interventions to include interventions
integrating apps, by assessing both clinical and self-management
outcomes, and by contributing to the emerging literature
regarding mHealth feasibility, usability, and acceptability.
Conclusion
The use of apps in mHealth has the potential to improve health
outcomes among those living with chronic diseases through
enhanced symptom control. Further evaluation of apps used in
mHealth, and more widely in eHealth, will be valuable. Research
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that involves populations traditionally marginalized and research
into how these tools can help to overcome barriers to chronic
disease management will be especially relevant. Further
innovation, optimization, and rigorous research around the
potential of apps in mHealth technology will move the field
toward the reality of improved health care delivery and
outcomes.
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